Laura Sainz-Gutierrez - Publications

Real-World Insights into Stage I-III Non-Small Cell Lung Cancer in Spain in the Pre-Immunotherapy Era Using AI Techniques: The IntellyLUNG Study.

Journal: Life (Basel, Switzerland)

Published: May 18, 2026

Unveiling miR-451a and miR-142-3p as prognostic markers in non-small cell lung cancer via small extracellular vesicle liquid biopsy.

Journal: Clinical and translational medicine

Published: December 16, 2025

SEOM-AEEMT consensus on occupational cancer and cancer-associated disability.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: June 06, 2025

Novel therapies targeting delta-like ligand 3 (DLL3) in pulmonary and gastroenteropancreatic neuroendocrine carcinomas.

Journal: Cancer treatment reviews

Published: May 26, 2025

First unscheduled hospitalization in advanced cancer as a prognostic indicator of poor survival and trigger for palliative care referral.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 06, 2025

Analysis of operability parameter changes in neoadjuvant treatment with chemotherapy and anti-PD-1/PD-L1.

Journal: Cancer treatment and research communications

Published: October 07, 2024

Cytokines and Pancreatic Ductal Adenocarcinoma: Exploring Their Relationship with Molecular Subtypes and Prognosis.

Journal: International journal of molecular sciences

Published: July 20, 2024

Analysis of tumor budding as a prognostic factor for recurrence in patients with stage II and III colon cancer. Experience in a tertiary hospital.

Journal: The oncologist

Published: April 09, 2024

Efficacy of second and third lines of treatment in advanced soft tissue sarcomas: a real-world study.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: January 28, 2023

The Relationship between the Expression of GATA4 and GATA6 with the Clinical Characteristics and Prognosis of Resectable Pancreatic Adenocarcinoma.

Journal: Biomedicines

Published: December 23, 2022

Clinical Score to Predict Recurrence in Patients with Stage II and Stage III Colon Cancer.

Journal: Cancers

Published: June 10, 2022

Identification of sSIGLEC5 and sLAG3 as New Relapse Predictors in Lung Cancer.

Journal: Biomedicines

Published: April 04, 2022